Apelin regulates the electrophysiological characteristics of atrial myocytes

Backgroud: Apelin, a potential agent for treating heart failure, has various ionic effects on ventricular myocytes. However, the effects of apelin on the atrium are not clear. The purpose of this study was to investigate the acute effects of apelin on the electrophysiological characteristics of atri...

全面介紹

Saved in:
書目詳細資料
Main Authors: Cheng C.-C., Weerateerangkul P., Lu Y.-Y., Chen Y.-C., Lin Y.-K., Chen S.-A., Chen Y.-J.
格式: Article
語言:English
出版: 2014
在線閱讀:http://www.scopus.com/inward/record.url?eid=2-s2.0-84871615822&partnerID=40&md5=27b04ce14d63f4dc4fa6b0e98928ff70
http://cmuir.cmu.ac.th/handle/6653943832/3940
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
實物特徵
總結:Backgroud: Apelin, a potential agent for treating heart failure, has various ionic effects on ventricular myocytes. However, the effects of apelin on the atrium are not clear. The purpose of this study was to investigate the acute effects of apelin on the electrophysiological characteristics of atrial myocytes. Method: Whole-cell patch-clamp techniques were used to investigate the action potential (AP) and ionic currents in isolated rabbit left atrial (LA) myocytes before and after the administration of apelin. Result: Apelin reduced LA AP duration measured at 90%, 50% and 20% repolarization of the amplitude by 11±3%, 24±5%, 30±7% at 1nM (n=11), and by 14±4%, 36±6% and 45±5% at 10nM (n=11), but not at 0·1nM. Apeline (0·1, 1, 10nM) did not change the amplitude, or resting membrane potential in LA myocytes. Apelin (1nM) increased sodium currents, ultra-rapid potassium currents and the reverse mode of sodium-calcium exchanger currents, but decreased late sodium currents and L-type calcium currents and did not change transient outward currents or inward rectifier potassium currents in LA myocytes. Conclusions: Apelin significantly changed the atrial electrophysiology with a shortening of AP duration, which may be caused by its effects on multiple ionic currents. © 2012 Stichting European Society for Clinical Investigation Journal Foundation.